Table 3:

Management in the ICU and clinical outcomes in 117 critically ill patients with COVID-19

VariableNo. (%) of patients*
ICU therapy
 Mechanical ventilation74 (63.2)
 Vasopressors65 (55.6)
 Neuromuscular blockade50 (42.7)
 High-flow nasal cannula43 (36.8)
 Prone ventilation21 (17.9)
 Continuous renal replacement therapy16 (13.7)
 Noninvasive positive-pressure ventilation15 (12.8)
 Inhaled pulmonary vasodilators8 (6.8)
 Extracorporeal membrane oxygenation3 (2.6)
Mechanical ventilation parameters 24 h after initiation, median (IQR)
 Plateau pressure, cm H2O22 (20–24)
 Positive end-expiratory pressure, cm H2O12 (10–14)
 FiO2, %50 (40–60)
 PaO2:FiO2180 (148–216)
 Tidal volume, mL/kg400 (350–450)
 Compliance, mL × cm H2O−135 (31–44)
Pharmacologic therapy
 Steroids28 (23.9)
 Tocilizumab4 (3.4)
 Hydroxychloroquine1 (0.9)
 Remdesivir0 (0.0)
Outcome
 Died in ICU18 (15.4)
 Still in ICU12 (10.3)
 Still in hospital (non-ICU)16 (13.7)
 Discharged from hospital71 (60.7)
 Reintubation within 48 h10 (8.5)
 Readmission to ICU within 72 h6 (5.1)
ICU length of stay, d, median (IQR)
 Overall9 (5–21)
 Patients discharged from ICU, n = 877 (3–16)
 Patients discharged from hospital, n = 716 (3–11)
 Deaths12 (7–18)
Hospital length of stay, d, median (IQR)
 Overall18 (11–30)
 Patients discharged from ICU, n = 8718 (10–32)
 Patients discharged from hospital, n = 7115 (8–22)
 Deaths13 (8–18)
Duration of mechanical ventilation, d, median (IQR)
 Overall, n = 7413.5 (8–22)
 Extubated, n = 5011.5 (6–18)
 Patients discharged from ICU, n = 4711 (6–16)
 Patients discharged from hospital, n = 348 (5–13)
 Deaths, n = 1513 (10–20)
  • Note: COVID-19 = coronavirus disease 2019, FiO2 = fraction of inspired oxygen, ICU = intensive care unit, IQR = interquartile range, PaO2 = partial pressure of oxygen.

  • * Unless stated otherwise.

  • Complete mechanical ventilation parameters 24 hours after initiation were available for 48 (64.9%) of 74 patients who underwent mechanical ventilation.